What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"
Kevin J. Knopp, insider at 908 Devices

Kevin J. Knopp Insider Information

CEO of 908 Devices
Dr. Kevin Knopp is a co-founder & CEO of 908 Devices Inc. An experienced high-tech entrepreneur, Kevin co-founded Ahura Scientific in 2002, and was Senior Vice President overseeing Operations, R&D and Safety and Security Sales through Ahura’s acquisition by Thermo Fisher Scientific in 2010, where he continued as Vice-President and Site Leader of the Portable Optical Analysis division. Kevin served as an independent board member for Crystal IS until its acquisition by Asahi-Kasei. He earned B.S.E.E from Boston University, M.S.E.E, and Ph.D. degrees in Optics from the University of Colorado. Kevin is an inventor on more than 20 US patents, is an author on more than a dozen refereed publications, and his products have received R&D 100, Business Week IDEA, GSN, CPhI Gold, Cygnus, and Frost & Sullivan awards.

What is Kevin J. Knopp's net worth?

The estimated net worth of Kevin J. Knopp is at least $14.14 million as of June 21st, 2022. Dr. Knopp owns 686,838 shares of 908 Devices stock worth more than $14,141,994 as of July 1st. This net worth approximation does not reflect any other assets that Dr. Knopp may own. Additionally, Dr. Knopp receives an annual salary of $760,000.00 as CEO at 908 Devices. Learn More about Kevin J. Knopp's net worth.

How old is Kevin J. Knopp?

Dr. Knopp is currently 49 years old. There are 5 older executives and no younger executives at 908 Devices. Learn More on Kevin J. Knopp's age.

What is Kevin J. Knopp's salary?

As the CEO of 908 Devices Inc., Dr. Knopp earned a total compensation package of $590,545.00 in 2020. Dr. Knopp earned a salary of $284,431.00, options awards of $218,794.00, non-equity compensation of $87,082.00, and other compensation of $238.00. Learn More on Kevin J. Knopp's salary.

How do I contact Kevin J. Knopp?

The corporate mailing address for Dr. Knopp and other 908 Devices executives is , , . 908 Devices can also be reached via phone at 857-254-1500 and via email at [email protected] Learn More on Kevin J. Knopp's contact information.

Has Kevin J. Knopp been buying or selling shares of 908 Devices?

Kevin J. Knopp has not been actively trading shares of 908 Devices over the course of the past ninety days. 0 shares of BMO Capital Markets stock in a transaction on Friday, July 1st. Learn More on Kevin J. Knopp's trading history.

Who are 908 Devices' active insiders?

Are insiders buying or selling shares of 908 Devices?

In the last year, insiders at the sold shares 29 times. They sold a total of 340,732 shares worth more than $9,120,641.43. The most recent insider tranaction occured on June, 27th when CFO Joseph H Iv Griffith sold 5,059 shares worth more than $96,525.72. Insiders at 908 Devices own 51.1 % of the company. Learn More about insider trades at 908 Devices.

Information on this page was last updated on 6/27/2022.

Kevin J. Knopp Insider Trading History at 908 Devices

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/21/2022Sell9,200$15.07$138,644.00686,838View SEC Filing Icon  
11/1/2021Sell20,000$34.62$692,400.00View SEC Filing Icon  
10/1/2021Sell20,000$33.65$673,000.00View SEC Filing Icon  
See Full Table

Kevin J. Knopp Buying and Selling Activity at 908 Devices

This chart shows Kevin J Knopp's buying and selling at 908 Devices by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

908 Devices Company Overview

908 Devices logo
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $20.59
Low: $19.35
High: $20.91

50 Day Range

MA: $15.97
Low: $13.30
High: $20.59

2 Week Range

Now: $20.59
Low: $12.60
High: $39.81

Volume

262,987 shs

Average Volume

314,959 shs

Market Capitalization

$646.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.62
What The White House Is NOT Telling You About The "Green Revolution."
Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.
Read The Full Story On This "Gold Rush"